Lenalidomide
Showing 951 - 975 of 1,173
MANTLE CELL LYMPHOMA Trial in Italy (Lenalidomide and Dexametasone)
Completed
- MANTLE CELL LYMPHOMA
- Lenalidomide and Dexametasone
-
Alessandria, Italy
- +16 more
Aug 16, 2016
Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) Trial in France (Lenalidomide)
Completed
- Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
- Lenalidomide
-
Amiens, France
- +23 more
Sep 22, 2016
B-cell Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in Buffalo (drug,
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- lenalidomide
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 26, 2016
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Durham (azacitidine, lenalidomide)
Terminated
- Follicular Lymphoma
- Marginal Zone Lymphoma
- azacitidine
- lenalidomide
-
Durham, North CarolinaDuke University Medical Center
Aug 1, 2016
Myeloma, Stem Cell Transplantation Trial in Houston (Lenalidomide, Melphalan, Stem Cell Infusion)
Completed
- Myeloma
- Stem Cell Transplantation
- Lenalidomide
- +2 more
-
Houston, TexasUT MD Anderson Cancer Center
May 5, 2016
Myeloma Trial in New Haven (Lenalidomide, Monocyte derived DCs loaded with KRN7000)
Completed
- Myeloma
- Lenalidomide
- Monocyte derived DCs loaded with KRN7000
-
New Haven, ConnecticutYale University School of Medicine
Jun 20, 2016
Advanced Cancers Trial in Houston (Lenalidomide, Bevacizumab, Sorafenib)
Completed
- Advanced Cancers
- Lenalidomide
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 1, 2016
CLL, Chronic Lymphocytic Leukemia Trial in Innsbruck, Salzburg (Lenalidomide)
Completed
- CLL
- Chronic Lymphocytic Leukemia
- Lenalidomide
-
Innsbruck, Tirol, Austria
- +1 more
May 25, 2016
Multiple Myeloma - Prevalence, Characteristics and Clinical
Unknown status
- Patient Non-adherence
- (no location specified)
Jun 1, 2016
Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Multiple Myeloma Trial in Australia, United States (pomalidomide,
Completed
- Multiple Myeloma in Relapse
- +2 more
- pomalidomide
- +2 more
-
Chicago, Illinois
- +5 more
Nov 20, 2017
Adult T Cell Leukemia/Lymphoma Trial in New York (Lenalidomide)
Completed
- Adult T Cell Leukemia/Lymphoma
- Lenalidomide
-
New York, New YorkColumbia University Medical Center
Apr 21, 2016
Myelodysplastic Syndrome Trial in Ulsan (Lenalidomide)
Unknown status
- Myelodysplastic Syndrome
- Lenalidomide
-
Ulsan, Korea, Republic ofUlsan University Hospital
May 10, 2016
Primary Amyloidosis of Light Chain Type Trial in Pavia (Pomalidomide and Dexamethasone)
Completed
- Primary Amyloidosis of Light Chain Type
- Pomalidomide and Dexamethasone
-
Pavia, ItalyCentro per lo Studio e la Cura delle Amiloidosi Sistemiche - Fon
Mar 8, 2018
Multiple Myeloma Trial in Worldwide (CC-5013 plus dexamethasone, Dexamethasone plus Placebo)
Completed
- Multiple Myeloma
- CC-5013 plus dexamethasone
- Dexamethasone plus Placebo
-
Camperdown, New South Wales, Australia
- +68 more
Sep 18, 2017
Plasma Cell Disorder Trial in Boston (Lenalidomide, Placebo)
Completed
- Plasma Cell Disorder
- Lenalidomide
- Placebo
-
Boston, Massachusetts
- +1 more
Apr 10, 2016
Melanoma Trial in Houston (Lenalidomide, Dacarbazine)
Completed
- Melanoma
- Lenalidomide
- Dacarbazine
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Apr 28, 2016
Prostate Cancer Trial in New York (Lenalidomide, Docetaxel, Prednisone)
Completed
- Prostate Cancer
- Lenalidomide
- +2 more
-
New York, New York
- +1 more
May 6, 2016
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (Lenalidomide, Fludarabine, Rituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Lenalidomide
- +2 more
-
Boston, Massachusetts
- +1 more
May 26, 2016
Waldenstrom's Macroglobulinemia Trial in Boston (CC-5103 (lenalidomide), Rituximab)
Terminated
- Waldenstrom's Macroglobulinemia
- CC-5103 (lenalidomide)
- Rituximab
-
Boston, Massachusetts
- +1 more
Mar 23, 2016
Lymphoma Trial in Chapel Hill, Nashville (Lenalidomide, Rituximab)
Anemia, Multiple Myeloma, Plasma Cell Tumor Trial in Cleveland (epoetin alfa)
Completed
- Anemia
- +2 more
- epoetin alfa
-
Cleveland, OhioCase Comprehensive Cancer Center
Jan 24, 2018